In addition, the methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) promoter was associated with pseudoprogression, and about 2/3 of GBM patients with MGMT methylation exhibited pseudoprogression (15). Here, MGMT is linked to glioblastoma.